Novel antiplatelet strategies targeting GPVI, CLEC-2 and tyrosine kinases

MH Harbi, CW Smith, PLR Nicolson, SP Watson… - Platelets, 2021 - Taylor & Francis
Antiplatelet medications comprise the cornerstone of treatment for diseases that involve
arterial thrombosis, including acute coronary syndromes (ACS), stroke and peripheral …

Molecular proteomics and signalling of human platelets in health and disease

J Huang, P Zhang, FA Solari, A Sickmann… - International Journal of …, 2021 - mdpi.com
Platelets are small anucleate blood cells that play vital roles in haemostasis and thrombosis,
besides other physiological and pathophysiological processes. These roles are tightly …

The structure of CLEC-2: mechanisms of dimerization and higher-order clustering

EM Martin, M Zuidscherwoude, L Morán, Y Di, A García… - Platelets, 2021 - Taylor & Francis
The platelet C-type lectin-like receptor CLEC-2 drives inflammation-driven venous
thrombosis in mouse models of thrombo-inflammatory disease with a minimal effect on …

Platelets, constant and cooperative companions of sessile and disseminating tumor cells, crucially contribute to the tumor microenvironment

WMJ Obermann, K Brockhaus, JA Eble - Frontiers in Cell and …, 2021 - frontiersin.org
Although platelets and the coagulation factors are components of the blood system, they
become part of and contribute to the tumor microenvironment (TME) not only within a solid …

Combining human platelet proteomes and transcriptomes: possibilities and challenges

J Huang, JWM Heemskerk, F Swieringa - Platelets, 2023 - Taylor & Francis
The anucleate human platelets contain a broad pattern of mRNAs and other RNA
transcripts. The high quantitative similarity of mRNAs in megakaryocytes and platelets from …

Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function

I Parra-Izquierdo, AR Melrose, J Pang… - Platelets, 2022 - Taylor & Francis
Several Janus kinase (JAK) inhibitors (jakinibs) have recently been approved to treat
inflammatory, autoimmune and hematological conditions. Despite emerging roles for JAKs …

[HTML][HTML] Histidine-rich glycoprotein stimulates human neutrophil phagocytosis and prolongs survival through CLEC1A

Y Takahashi, H Wake, M Sakaguchi… - The Journal of …, 2021 - journals.aai.org
Histidine-rich glycoprotein (HRG) is a multifunctional plasma protein and maintains the
homeostasis of blood cells and vascular endothelial cells. In the current study, we …

Mild hyperlipidemia in mice aggravates platelet responsiveness in thrombus formation and exploration of platelet proteome and lipidome

JP van Geffen, F Swieringa, K van Kuijk… - Scientific Reports, 2020 - nature.com
Hyperlipidemia is a well-established risk factor for cardiovascular diseases. Millions of
people worldwide display mildly elevated levels of plasma lipids and cholesterol linked to …

Platelet “-omics” in health and cardiovascular disease

C Gutmann, A Joshi, M Mayr - Atherosclerosis, 2020 - Elsevier
The importance of platelets for cardiovascular disease was established as early as the 19th
century. Their therapeutic inhibition stands alongside the biggest achievements in medicine …

F11R/JAM-A: why do platelets express a molecule which is also present in tight junctions?

P Kamola, A Babinska, T Przygodzki - Platelets, 2023 - Taylor & Francis
Abstract F11 receptor (F11R)/Junctional Adhesion Molecule–A (JAM-A) is a transmembrane
protein which belongs to the immunoglobulin superfamily of cell adhesion molecules …